Indonesia’s pandemic preparedness is being strengthened by innovative partnerships and technology, including gene editing tools. The country’s recent initiatives emphasize rapid vaccine development and genetic research to combat infectious diseases. The strategic collaboration between local manufacturers and international organizations aims to create a robust response framework for potential pandemics. As gene editing innovations like CRISPR gain momentum, they play a crucial role in accelerating vaccine development processes, enabling rapid responses to emerging threats. This synthesis of capabilities not only enhances Indonesia’s health security but also positions it as a leader in global health innovation, illustrating the synergy between biotechnology and public health initiatives.
